
Heading to #JPM2027? Our team will be in San Francisco Jan 11 to 14 to discuss how generative AI can help wiyour pipeline! #DrugDiscovery. #AIDD #GenAIinPharma hubs.ly/Q04FrzNR0

State-of-the-art generative #machinelearning for #drugdiscovery

Heading to #JPM2027? Our team will be in San Francisco Jan 11 to 14 to discuss how generative AI can help wiyour pipeline! #DrugDiscovery. #AIDD #GenAIinPharma hubs.ly/Q04FrzNR0

This week our team is at #BIOEurope in Cologne, meeting pharma and biotech teams about generative molecular design. Enki™ arrives with 873 pre-trained targets, see if your target is on our list: hubs.ly/Q04DTlQ00 #DrugDiscovery #GenerativeAI #AIDD #AIinPharma

Peter Guzzo and Valentin Beuchillot will be heading to #BIOEurope in Cologne next week. Still a few openings left on the calendar! Reach out on the partnering platform or bd@variational.ai hubs.ly/Q04D1lw_0 #AIDD #AIDrugDiscovery #AIinPharma #GenAIinPharma #DrugDiscovery

Designing brain-penetrant ATR inhibitor is a hard problem; screening might not be the right way to solve it. Rakovina’s kt-5000AI program, built on Enki™, gets a live walkthrough Nov 5, 9:30 a.m. PT. #DrugDiscovery hubs.ly/Q04D3mQY0

Next week Handol Kim and Valentin Beuchillot are at Invest in BC 2026, hosted by Life Sciences BC and presented by Lumira Ventures, during Life Sciences Investment Week. Come meet with us! #DrugDiscovery #GenerativeAI #AIDD #Biotech #VariationalAI #InvestInBC

We are in Seoul this week for BIOPLUS-INTERPHEX KOREA, with Canada as Country of Honour 🇰🇷 🇨🇦 Come find us at the Canadian Pavilion, or reach out at bd@variational.ai 📍 COEX, Seoul 🗓 October 28 to 30 #DrugDiscovery #GenerativeAI #AIDD #SmallMolecules #VariationalAI #BIX2026

Eight ATR inhibitors have entered the clinic. None is brain-penetrant. @rakovina_rkv designed kt-5000 with Enki™ to meet that profile: 122 compounds, ~2 years, ~US$1M direct external spend to candidate-ready. Full case study: hubs.ly/Q04B-nd00 #AIDD #DrugDiscovery

SK Life Science Labs selects our Enki™ platform for generative AI-driven lead discovery. We will deliver new lead series for an undisclosed SK LSL program: “a faster path to promising leads for challenging targets,” says CSO Ryan Kruger. #AIDD hubs.ly/Q04BG7fj0

We’re in Seoul for BIX 2026 with the Canadian delegation, taking partnering meetings on AI-enabled lead generation and optimization all three days. Our CEO Handol Kim also moderates the Oct 30 panel on real value in AI drug discovery. #AIDD #DrugDiscovery hubs.ly/Q04BdqTr0

Canada produces strong AI research. Turning it into Canadian #DrugDiscovery companies is the harder part. @S49Research publishes its AI for drug discovery report today, with input from our CEO Handol Kim. #GenerativeAI #AIDD hubs.ly/Q04zyMMm0

Don't miss our CEO, Handol Kim, on BC Tech's Scaleup Academy panel "BC's HealthTech AI Advantage" this Wednesday, Oct 7, 11am PT, online. hubs.ly/Q04zbLtr0

Come meet with @VariationalAI this week at Discovery on Target Boston! Valentin Beuchillot and Peter Guzzo present the poster C099: novel PRMT6 inhibitors via AI-driven design and synthesis. #AIDD #DrugDiscovery #BostonDOT hubs.ly/Q04yM8Lx0

Canada isn't short on AI research 🇨🇦 Thank you, @wearebctech for naming Variational AI a 2026 Technology Impact Awards finalist: Gamechanger - AI and Company of the Year - Growth. 📍Join the Gala on Oct 29, at Parq Vancouver. hubs.ly/Q04ydY-80 #2026TIAs #AIDD #GenAI #AI

Hard targets get easier with better starting chemistry! Next week at Discovery on Target Boston (Sept 28-Oct 1), Peter Guzzo presents poster C099: novel PRMT6 inhibitors via AI-driven design and synthesis. #AIDD #DrugDiscovery #BostonDOT hubs.ly/Q04xZ-Wd0

#ALLIN2026 wrapped in Montréal 🇨🇦 Thanks to @ScaleAICanada for the great organization and for bringing the AI Canadian community together! #GenerativeAI #AI #GenAI #VariationalAI

@VariationalAI on the road! Our Co-Founder & CEO is traveling to two Canadian stages next week. @BIOTECanada #BIONATION2026 in Ottawa on Sept. 22 and the @Bioalberta #HLSS2026 in Calgary on Sept 24. 🇨🇦 #AIDD hubs.ly/Q04xsXxW0 #AIDrugDiscovery #GenAIinPharma